Progress in Research on Stem Cells in Neonatal Refractory Diseases

Overview

Journal J Pers Med

Date 2023 Aug 25

PMID 37623531

Authors

Fangjun Huang

Yang He

Meng Zhang

Keren Luo

Jiawen Li

Jiali Li

Xinyu Zhang

Xiaoyan Dong

Jun Tang

Affiliations

Soon will be listed here.

Abstract

With the development and progress of medical technology, the survival rate of premature and low-birth-weight infants has increased, as has the incidence of a variety of neonatal diseases, such as hypoxic-ischemic encephalopathy, intraventricular hemorrhage, bronchopulmonary dysplasia, necrotizing enterocolitis, and retinopathy of prematurity. These diseases cause severe health conditions with poor prognoses, and existing control methods are ineffective for such diseases. Stem cells are a special type of cells with self-renewal and differentiation potential, and their mechanisms mainly include anti-inflammatory and anti-apoptotic properties, reducing oxidative stress, and boosting regeneration. Their paracrine effects can affect the microenvironment in which they survive, thereby affecting the biological characteristics of other cells. Due to their unique abilities, stem cells have been used in treating various diseases. Therefore, stem cell therapy may open up the possibility of treating such neonatal diseases. This review summarizes the research progress on stem cells and exosomes derived from stem cells in neonatal refractory diseases to provide new insights for most researchers and clinicians regarding future treatments. In addition, the current challenges and perspectives in stem cell therapy are discussed.

Citing Articles

Therapeutic role of extracellular vesicles from human umbilical cord mesenchymal stem cells and their wide therapeutic implications in inflammatory bowel disease and other inflammatory disorder.

Azhar Ud Din M, Wan A, Chu Y, Zhou J, Yan Y, Xu Z Front Med (Lausanne). 2024; 11:1406547.

PMID: 39139783 PMC: 11319305. DOI: 10.3389/fmed.2024.1406547.

References

Murphy S, Atala A . Amniotic fluid and placental membranes: unexpected sources of highly multipotent cells. Semin Reprod Med. 2013; 31(1):62-8. DOI: 10.1055/s-0032-1331799. View

Bottai D, Cigognini D, Nicora E, Moro M, Grimoldi M, Adami R . Third trimester amniotic fluid cells with the capacity to develop neural phenotypes and with heterogeneity among sub-populations. Restor Neurol Neurosci. 2012; 30(1):55-68. DOI: 10.3233/RNN-2011-0620. View

Nabetani M, Shintaku H, Hamazaki T . Future perspectives of cell therapy for neonatal hypoxic-ischemic encephalopathy. Pediatr Res. 2017; 83(1-2):356-363. DOI: 10.1038/pr.2017.260. View

Ohshima M, Taguchi A, Sato Y, Ogawa Y, Saito S, Yamahara K . Evaluations of Intravenous Administration of CD34+ Human Umbilical Cord Blood Cells in a Mouse Model of Neonatal Hypoxic-Ischemic Encephalopathy. Dev Neurosci. 2017; 38(5):331-341. DOI: 10.1159/000454830. View

Fisher S, Cutler A, Doree C, Brunskill S, Stanworth S, Navarrete C . Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft-versus-host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition. Cochrane Database Syst Rev. 2019; 1:CD009768. PMC: 6353308. DOI: 10.1002/14651858.CD009768.pub2. View

McCulloh C, Olson J, Wang Y, Zhou Y, Tengberg N, Deshpande S . Treatment of experimental necrotizing enterocolitis with stem cell-derived exosomes. J Pediatr Surg. 2018; 53(6):1215-1220. PMC: 5994352. DOI: 10.1016/j.jpedsurg.2018.02.086. View

Jahan S, Kumar D, Kumar A, Rajpurohit C, Singh S, Srivastava A . Neurotrophic factor mediated neuronal differentiation of human cord blood mesenchymal stem cells and their applicability to assess the developmental neurotoxicity. Biochem Biophys Res Commun. 2016; 482(4):961-967. DOI: 10.1016/j.bbrc.2016.11.140. View

Naji A, Eitoku M, Favier B, Deschaseaux F, Rouas-Freiss N, Suganuma N . Biological functions of mesenchymal stem cells and clinical implications. Cell Mol Life Sci. 2019; 76(17):3323-3348. PMC: 11105258. DOI: 10.1007/s00018-019-03125-1. View

Chen H, Zhang H, Zheng Y, Min X, Luo Y, Zhou W . Prolyl hydroxylase 2 silencing enhances the paracrine effects of mesenchymal stem cells on necrotizing enterocolitis in an NF-κB-dependent mechanism. Cell Death Dis. 2020; 11(3):188. PMC: 7075868. DOI: 10.1038/s41419-020-2378-3. View

10.

Qian D, Gong J, He Z, Hua J, Lin S, Xu C . Bone Marrow-Derived Mesenchymal Stem Cells Repair Necrotic Pancreatic Tissue and Promote Angiogenesis by Secreting Cellular Growth Factors Involved in the SDF-1 α /CXCR4 Axis in Rats. Stem Cells Int. 2015; 2015:306836. PMC: 4355908. DOI: 10.1155/2015/306836. View

11.

Zhuxiao R, Fang X, Wei W, Shumei Y, Jianlan W, Qiuping L . Prevention for moderate or severe BPD with intravenous infusion of autologous cord blood mononuclear cells in very preterm infants-a prospective non-randomized placebo-controlled trial and two-year follow up outcomes. EClinicalMedicine. 2023; 57:101844. PMC: 9971511. DOI: 10.1016/j.eclinm.2023.101844. View

12.

Palmer S, Thomas S, Cooke R, Low D, Fysh W, Murphy J . Birthweight-specific risk factors for necrotising enterocolitis. J Epidemiol Community Health. 1987; 41(3):210-4. PMC: 1052622. DOI: 10.1136/jech.41.3.210. View

13.

Hochheuser C, Kunze N, Tytgat G, Voermans C, Timmerman I . The Potential of Mesenchymal Stromal Cells in Neuroblastoma Therapy for Delivery of Anti-Cancer Agents and Hematopoietic Recovery. J Pers Med. 2021; 11(3). PMC: 7996318. DOI: 10.3390/jpm11030161. View

14.

van Velthoven C, Kavelaars A, van Bel F, Heijnen C . Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav Immun. 2009; 24(3):387-93. DOI: 10.1016/j.bbi.2009.10.017. View

15.

Hakes A, Brand A . Neural stem cell dynamics: the development of brain tumours. Curr Opin Cell Biol. 2019; 60:131-138. DOI: 10.1016/j.ceb.2019.06.001. View

16.

Ivanovic Z . Mesenchymal - Stem and non-Stem - Cells: The name of the rose. Transfus Clin Biol. 2023; 30(3):305-306. DOI: 10.1016/j.tracli.2023.03.006. View

17.

Zhang Y, Xu Y, Kong H, Zhang J, Chan H, Wang J . Microneedle system for tissue engineering and regenerative medicine. Exploration (Beijing). 2023; 3(1):20210170. PMC: 10190997. DOI: 10.1002/EXP.20210170. View

18.

Edgar J . Q&A: What are exosomes, exactly?. BMC Biol. 2016; 14:46. PMC: 4906597. DOI: 10.1186/s12915-016-0268-z. View

19.

Phuong Trinh T, Li Calzi S, Shaw L, Yoder M, Grant M . Promoting vascular repair in the retina: can stem/progenitor cells help?. Eye Brain. 2017; 8:113-122. PMC: 5398749. DOI: 10.2147/EB.S94451. View

20.

Mulcahy L, Pink R, Carter D . Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014; 3. PMC: 4122821. DOI: 10.3402/jev.v3.24641. View